A comprehensive review explores cannabidiol brain tumor antiepileptic mechanisms and suggests potential antitumor activity in CNS cancers. The analysis identifies multiple pathways through which CBD and other antiepileptic drugs might combat brain tumors beyond seizure control. However, clinical validation of these theoretical mechanisms remains needed.
Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation.
A new preclinical study demonstrates that CBD glioblastoma prevention may be possible through extended pretreatment in mice. While promising, this early research requires extensive human studies before any clinical applications. Dr. Caplan explains what patients should understand about this brain cancer prevention research.